| Dr Selden Edmund Spencer, | |
|
1015 Duff Ave, Ames, IA 50010-3014 | |
| (515) 239-4435 | |
| (515) 239-4758 |
| Full Name | Dr Selden Edmund Spencer |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 46 Years |
| Location | 1015 Duff Ave, Ames, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275514606 | NPI | - | NPPES |
| 0218370 | Medicaid | IA |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Iowa Hospital & Clinics | Iowa city, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcfarland Clinic Pc | 1254244239 | 320 |
| State University Of Iowa | 7618884230 | 1476 |
News Archive
Lab personnel say worries are mounting over the safety of a rapid coronavirus test by Abbott Laboratories that President Donald Trump has repeatedly lauded - particularly, the risk of infection to those handling it.
Kolltan Pharmaceuticals, Inc. today announced the presentation of data from a preclinical study evaluating KTN0158 in dogs with spontaneous mast cell tumors. KTN0158 is a proprietary, humanized anti-KIT IgG1 monoclonal antibody drug candidate being developed as a potential therapy for cancer and mast cell-related diseases.
It is common practice to insert totally implantable venous access devices (TIVADs) in cancer patients beginning a course of chemotherapy to eliminate potential peripheral venous access problems; however, risk factors impacting the survival of TIVADs remain unclear.
Wyeth Pharmaceuticals, a division of Wyeth, announces findings from a placebo-controlled Phase 3 study of bazedoxifene 20 mg extended to five years, which indicated a significant reduction versus placebo in new vertebral fractures in postmenopausal women with osteoporosis.
Omega-3 fatty acids found in oily fish may have diverse health-promoting effects, potentially protecting the immune, nervous, and cardiovascular systems.
› Verified 5 days ago
| Entity Name | Mcfarland Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639135643 PECOS PAC ID: 1254244239 Enrollment ID: O20031106000338 |
News Archive
Lab personnel say worries are mounting over the safety of a rapid coronavirus test by Abbott Laboratories that President Donald Trump has repeatedly lauded - particularly, the risk of infection to those handling it.
Kolltan Pharmaceuticals, Inc. today announced the presentation of data from a preclinical study evaluating KTN0158 in dogs with spontaneous mast cell tumors. KTN0158 is a proprietary, humanized anti-KIT IgG1 monoclonal antibody drug candidate being developed as a potential therapy for cancer and mast cell-related diseases.
It is common practice to insert totally implantable venous access devices (TIVADs) in cancer patients beginning a course of chemotherapy to eliminate potential peripheral venous access problems; however, risk factors impacting the survival of TIVADs remain unclear.
Wyeth Pharmaceuticals, a division of Wyeth, announces findings from a placebo-controlled Phase 3 study of bazedoxifene 20 mg extended to five years, which indicated a significant reduction versus placebo in new vertebral fractures in postmenopausal women with osteoporosis.
Omega-3 fatty acids found in oily fish may have diverse health-promoting effects, potentially protecting the immune, nervous, and cardiovascular systems.
› Verified 5 days ago
| Entity Name | State University Of Iowa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477554814 PECOS PAC ID: 7618884230 Enrollment ID: O20031107000060 |
News Archive
Lab personnel say worries are mounting over the safety of a rapid coronavirus test by Abbott Laboratories that President Donald Trump has repeatedly lauded - particularly, the risk of infection to those handling it.
Kolltan Pharmaceuticals, Inc. today announced the presentation of data from a preclinical study evaluating KTN0158 in dogs with spontaneous mast cell tumors. KTN0158 is a proprietary, humanized anti-KIT IgG1 monoclonal antibody drug candidate being developed as a potential therapy for cancer and mast cell-related diseases.
It is common practice to insert totally implantable venous access devices (TIVADs) in cancer patients beginning a course of chemotherapy to eliminate potential peripheral venous access problems; however, risk factors impacting the survival of TIVADs remain unclear.
Wyeth Pharmaceuticals, a division of Wyeth, announces findings from a placebo-controlled Phase 3 study of bazedoxifene 20 mg extended to five years, which indicated a significant reduction versus placebo in new vertebral fractures in postmenopausal women with osteoporosis.
Omega-3 fatty acids found in oily fish may have diverse health-promoting effects, potentially protecting the immune, nervous, and cardiovascular systems.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Selden Edmund Spencer, 1015 Duff Ave, Ames, IA 50010-3014 Ph: (515) 239-4435 | Dr Selden Edmund Spencer, 1015 Duff Ave, Ames, IA 50010-3014 Ph: (515) 239-4435 |
News Archive
Lab personnel say worries are mounting over the safety of a rapid coronavirus test by Abbott Laboratories that President Donald Trump has repeatedly lauded - particularly, the risk of infection to those handling it.
Kolltan Pharmaceuticals, Inc. today announced the presentation of data from a preclinical study evaluating KTN0158 in dogs with spontaneous mast cell tumors. KTN0158 is a proprietary, humanized anti-KIT IgG1 monoclonal antibody drug candidate being developed as a potential therapy for cancer and mast cell-related diseases.
It is common practice to insert totally implantable venous access devices (TIVADs) in cancer patients beginning a course of chemotherapy to eliminate potential peripheral venous access problems; however, risk factors impacting the survival of TIVADs remain unclear.
Wyeth Pharmaceuticals, a division of Wyeth, announces findings from a placebo-controlled Phase 3 study of bazedoxifene 20 mg extended to five years, which indicated a significant reduction versus placebo in new vertebral fractures in postmenopausal women with osteoporosis.
Omega-3 fatty acids found in oily fish may have diverse health-promoting effects, potentially protecting the immune, nervous, and cardiovascular systems.
› Verified 5 days ago
Gabrielle S Barloon, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 600 5th St, Ste 200, Ames, IA 50010 Phone: 515-232-2051 Fax: 515-232-2775 | |
Juan A Acosta, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1015 Duff Avenue, Mcfarland Clinic Pc, Ames, IA 50010 Phone: 515-239-4435 Fax: 515-239-4758 | |
Dr. Michael J. Kitchell, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4114 Edgewater Dr, Ames, IA 50010 Phone: 515-292-3817 | |
Dr. Semira Ramic, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1015 Duff Avenue, Ames, IA 50010 Phone: 515-239-4435 Fax: 515-239-4758 | |
Anna Elizabeth Statz, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1111 Duff Ave., Ames, IA 50010 Phone: 515-239-2011 | |
Dr. Anu Baweja, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1015 Duff Avenue, Ames, IA 50010 Phone: 515-239-4435 Fax: 515-239-4758 |